Onder Ergonul - Infectious Diseases

Author Information

Onder Ergonul is a distinguished scholar associated with the Department of Infectious Diseases and Clinical Microbiology at the School of Medicine, Koç University, located in Istanbul, Turkey. His research work primarily revolves around infectious diseases, with a significant focus on the clinical and public health aspects of pandemics and infectious disease management.

Research Contributions

Onder Ergonul has made substantial contributions to the field of infectious diseases, particularly in the context of the COVID-19 pandemic. His work includes critical evaluations of drug treatments, clinical management guidelines, and the equity of access to COVID-19 testing. He has also explored the inappropriate use of treatments such as ivermectin during the pandemic. Beyond COVID-19, Ergonul has researched the epidemiology of Crimean-Congo Hemorrhagic Fever Virus across different continents and has made significant findings in the prevention of healthcare-associated infections and the role of obesity in COVID-19 outcomes.

Aliases

Onder Ergonul is also known by several variations of his name in academic publications, including O Ergonul and O. Ergonul. These aliases are used interchangeably in his scholarly articles.

Publication and Citation Metrics

Metric	Value
Citation Count	5211
h-index	37
Paper Count	170

Publications:

ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply

DOI: 10.1016/j.cmi.2021.12.025

Year: 2022

The silent and dangerous inequity around access to COVID-19 testing: A call to action

DOI: 10.1016/j.eclinm.2021.101230

Year: 2022

Inappropriate use of ivermectin during the COVID-19 pandemic: primum non nocere!

DOI: 10.1016/j.cmi.2022.03.022

Year: 2022

The Effectiveness of Bundle Applications in the Prevention of Central Line-associated Bloodstream Infections: Nine Years of Observation

DOI: 10.36519/idcm.2022.114

Year: 2022

Crimean-Congo Hemorrhagic Fever Virus in Asia, Africa and Europe

DOI: 10.3390/microorganisms9091907

Year: 2021

The Role of Obesity in Predicting the Clinical Outcomes of COVID-19

DOI: 10.1159/000517180

Year: 2021

Elimination of healthcare associated Acinetobacter baumannii infection in a highly endemic region.

DOI: 10.1016/j.ijid.2021.10.011

Year: 2021

Physical rehabilitation in intensive care unit in acute respiratory distress syndrome patients with COVID-19.

DOI: 10.23736/S1973-9087.21.06551-5

Year: 2021

ESCMID COVID-19 living guidelines: drug treatment and clinical management

DOI: 10.1016/j.cmi.2021.11.007

Year: 2021

Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic

DOI: 10.1016/j.eclinm.2021.101053

Year: 2021

How are Funds Allocated?

How is Plasmodium falciparum transmitted?

What is the Impact on Public Health?

What are Antifungals?

What is Clostridium Botulinum?

Why Do Pathogens Alter Glycolysis?

How is Strep Throat Diagnosed?

Are There Diagnostic Implications?

How Do Antiviral Drugs Work?

What are Influenza Antivirals?

Partnered Content Networks

Relevant Topics